Partners

BDD has world-class expertise in developing and clinically testing innovative pharmaceutical products. Our development strategies are underpinned by our understanding of biopharmaceutics, which has evolved over years of experience in visualizing in vivo performance of products using gamma scintigraphy. This enables us to identify and anticipate drug delivery challenges and apply this knowledge to our formulation development projects from an early stage. BDD are specialists in the formulation of double / triple pulse and complex release tablet formulations using our patented technology OralogiK™.

Camargo Pharmaceutical Services is the most experienced team of experts providing comprehensive drug development services specialized for the 505(b)(2) approval pathway and global equivalent processes. By assessing the scientific, medical, regulatory, and commercial viability of product development opportunities, Camargo systematically builds and executes robust development plans that align with business strategies and ensure Agency buy-in every step of the way.

Darrow Associates, Inc. is an award-winning investor relations and financial communications consultancy serving the needs of select micro and small-cap companies. Strategic programs are implemented with high level counsel provided by the firm’s executive consultants and focused on attaining results.

Dr. Vince Clinical Research (DVCR) is a full-service CRO (Contract Research Organization) with a custom-built, green-designed headquarters and research complex encompassing three buildings in Overland Park, KS. DVCR’s complex includes a 90-bed clinical pharmacology unit featuring a combination of luxurious and private research suites and a GMP compliant pharmacy with positive and negative pressure compounding rooms. DVCR specializes in conducting clinical trials for both healthy normal volunteers and patient populations in a wide variety of early phase trials. By leveraging both technology and one of the country’s most experienced leadership teams, DVCR provides Smarter, Faster Data to their biopharmaceutical clients.

Elixir Health Public Relations delivers the right mix of strategic life science communications that create powerful chemistry with key stakeholders, advancing our clients’ communications and, ultimately, their business goals. Our approach brings together a high level of scientific, corporate and marketing expertise, enabling us to rapidly and firmly grasp business objectives and strategic communications needs, and to seamlessly partner with clients in order to achieve meaningful results. Based upon the extensive experience we have across all major healthcare categories – in concert with various forms of qualitative and quantitative research – we are able to define the most effective communications strategies to engage, educate and activate target audiences.

Global Pharmaceutical Partners have proficiency in attracting development partners, and international licensing deals. Their expertise spans specialty Pharma companies, generic, innovative and hybrid companies because of their deep Pharma expertise and connections.

Lowenstein Sandler is a national law firm with approximately 300 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology.

A Boston institution since 1933, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo is now a national powerhouse, claiming such blue chippers as Biogen Idec and General Electric as clients. Bay State pedigree notwithstanding, Mintz Levin’s gaze has shifted westward-namely to the IP-rich tech and biotech hubs of San Diego and Silicon Valley, and recently to San Francisco.

PCI is committed to supporting clients at every stage of the of the clinical cycle, delivering best-in-class services efficiently and effectively. We are experts and innovators, sharing the same goal of delivering life-changing therapies to patients worldwide.

Premier’s experienced research professionals are capable of managing even the most complex clinical research studies from Phase 1 to Phase 4. Our therapeutically focused teams have the knowledge and experience necessary to effectively manage situations as they arise, and our approach is firmly grounded in comprehensive project management principles and well-defined processes.

Rho is a global, privately held contract research organization (CRO) headquartered in Research Triangle Park, a biotech hub in North Carolina, US. Rho provides a full range of drug development services, from program strategy through to clinical trials and marketing applications. For more than 35 years, Rho has been a trusted partner to some of the most innovative pharmaceutical, biotechnology and medical device companies as well as academic and government organizations. Dedicated to service excellence and cross-functional collaboration, Rho’s therapeutic expertise, employee focus and commitment to strong site relationships change what it means to work with a CRO – accelerating time to market, maximizing ROI, and delivering consistent, smarter and more efficient programs. Experience Rho by following the company on Facebook, LinkedIn and Twitter.

With over 35 years of experience in solving complex manufacturing problems, Societal™️ CDMO, a bi-coastal US-based CDMO, offers formulation and analytical development, clinical trial manufacturing, labeling, and distribution, commercial manufacturing, end-to-end regulatory support, aseptic fill/finish, lyophilization and packaging for a wide range of therapeutic dosage forms. We are focused on meeting our clients’ business objectives and providing quality drug products to the patients we ultimately serve.